London is the setting for the next edition of a
Author: Michael
Immorta Bio is developing autologous stem cell a
New COO Michael Ringel says company is confident
Company gears up for pivotal trials of AI-develo
New research highlights the dominant role of env
Company’s platform integrates labs and more th
Regenerative medicine startup aims to regenerate
Therapeutic interventions that stop or reverse a
PET tracer derived from an ALS treatment provide
Company files patent for treatment of chemothera